Suppr超能文献

相似文献

1
Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice.
Am J Pathol. 2001 Feb;158(2):555-62. doi: 10.1016/S0002-9440(10)63997-1.
2
Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau.
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13896-901. doi: 10.1073/pnas.202205599. Epub 2002 Oct 4.
3
Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau.
Neurobiol Dis. 2001 Dec;8(6):1036-45. doi: 10.1006/nbdi.2001.0439.
4
A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Exp Neurol. 2008 Jul;212(1):71-84. doi: 10.1016/j.expneurol.2008.03.007. Epub 2008 Mar 21.
5
[Analysis of mouse model exhibiting neurofibrillary changes].
Rinsho Shinkeigaku. 2001 Dec;41(12):1111-2.
6
Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils.
Science. 2001 Aug 24;293(5534):1491-5. doi: 10.1126/science.1062097.
8
Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
Acta Neuropathol. 2014 May;127(5):685-98. doi: 10.1007/s00401-014-1259-1. Epub 2014 Feb 15.
9
Divergent phosphorylation pattern of tau in P301L tau transgenic mice.
Eur J Neurosci. 2008 Jul;28(1):137-47. doi: 10.1111/j.1460-9568.2008.06318.x.
10
Effects of alpha-tocopherol on an animal model of tauopathies.
Free Radic Biol Med. 2004 Jul 15;37(2):176-86. doi: 10.1016/j.freeradbiomed.2004.04.037.

引用本文的文献

1
Three-repeat and four-repeat tau isoforms form different oligomers.
Protein Sci. 2022 Mar;31(3):613-627. doi: 10.1002/pro.4257. Epub 2022 Jan 7.
4
Developmental Pathogenicity of 4-Repeat Human Tau Is Lost with the P301L Mutation in Genetically Matched Tau-Transgenic Mice.
J Neurosci. 2020 Jan 2;40(1):220-236. doi: 10.1523/JNEUROSCI.1256-19.2019. Epub 2019 Nov 4.
5
The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer's Disease (AD).
Int J Mol Sci. 2019 Sep 20;20(19):4661. doi: 10.3390/ijms20194661.
6
Loss in efficacy measures of tolfenamic acid in a tau knock-out model: Relevance to Alzheimer's disease.
Exp Biol Med (Maywood). 2019 Oct;244(13):1062-1069. doi: 10.1177/1535370219871249. Epub 2019 Aug 26.
7
9
Tau physiology and pathomechanisms in frontotemporal lobar degeneration.
J Neurochem. 2016 Aug;138 Suppl 1(Suppl Suppl 1):71-94. doi: 10.1111/jnc.13600. Epub 2016 Jun 15.

本文引用的文献

3
Neurodegenerative tauopathies: human disease and transgenic mouse models.
Neuron. 1999 Nov;24(3):507-10. doi: 10.1016/s0896-6273(00)81106-x.
4
Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein.
Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13450-5. doi: 10.1073/pnas.96.23.13450.
5
Purification of paired helical filament tau and normal tau from human brain tissue.
Methods Enzymol. 1999;309:81-9. doi: 10.1016/s0076-6879(99)09008-4.
7
Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17.
Science. 1998 Dec 4;282(5395):1914-7. doi: 10.1126/science.282.5395.1914.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验